DOCSLIB.ORG

Contraception Access Subsidy (BCAS) the Contraception Access Research Team 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Contraception Access Subsidy (BCAS) the Contraception Access Research Team 2018 British Columbia’s Contraception Access Subsidy (BCAS) The Contraception Access Research Team 2018 Contraception Cost-Effectiveness in British Columbia 2018 June 22 Prepared by the UBC Contraception Access Research Team, Contraception Cost-Effectiveness Modelling Study Investigators Principal Investigators: Wendy V. Norman, MD, MHSc Stirling Bryan, PhD Principal Knowledge User: Dr. Bonnie Henry and recognizing the input over many years of her predecessor, Dr. Perry Kendall, who are the current and most recent Provincial Health Officers, Government of BC Investigators: Saied Samiedaluie, PhD (primary model development and testing); Steven Shechter, PhD (modeling oversight and expert lead); Janusz Kaczorowski, PhD; Rollin Brant, PhD; Sheila Dunn, MD, MSc; Jean Shoveller, PhD; Gina Ogilvie, MD, DrPH; Jan Christilaw, MD, MHSc. This model incorporates data collected through the 2015 BC Sexual Health Survey. See our separate report of CSHS results 2017 June 15, http://cart-grac.ubc.ca/research/current-projects/. Contents EXECUTIVE SUMMARY IV SIMULATION ResULTs 9 A Policy Tool for British Columbia IV Simulation Results with No Policy Change 9 A model to simulate health outcomes and Health System Costs for All Women Under Status Quo 9 health systems costs resulting from policy interventions to reduce unintended pregnancy IV Simulation Results with Implementation of a New BC Contraception Access Subsidy (BCAS) Policy 10 Is it more expensive for a health system to pay for the care of unintended pregnancies, or Reduction in Pregnancies, by Number and Percent 10 to subsidize contraception? IV Costs for all Women under Status Quo and BCAS Policies, for Pregnancy Care, Contraception DEVELOPING THE MODEL 1 and Total 11 Project Overview 1 SUMMARY 13 Background 1 Project Components 4 APPENDIX I 15 Research Question 4 Costs Related to Pregnancy Care and Contraception by Responsible Government Division 15 Aim 4 Costs for Status Quo 15 Objectives 4 Costs for BCAS Policy Options 15 The 2015 BC Sexual Health Survey 4 Costs Differences when Comparing BCAS Policy to Status Quo 16 THE SIMULATION MOdeL DECISION SUPPORT TOOL 6 How the Simulation Model Works 6 APPENDIX II 20 Model Parameters 7 References 20 Model Assumptions 7 Simulation Model Inputs 8 Cost for Contraceptive Methods 8 Cost for Pregnancy Outcomes 8 Executive Summary A Policy Tool for British Columbia A model to simulate health outcomes and health survey throughout BC to collect high quality population systems costs resulting from policy interventions to data to determine the indicators of pregnancy intention, reduce unintended pregnancy contraceptive method use, and sexual activity. We used these data as inputs for a simulation model to ascertain Unintended pregnancy is common in British Columbia (BC) provincial health system costs and outcomes associated with where 40 % of pregnancies, including a third of all births, are unintended pregnancy and project costs associated with unintended at the time of conception. Compounding the contraceptive subsidy. Simulation models were developed burden and system costs of managing unintended pregnancy by UBC faculty of the Sauder School of Business, the School is the significant equity gradient between families able, and of Population and Public Health and Center for Clinical those who face challenges, to time and space their births. Epidemiology and Evaluation. Vulnerable populations with the least favourable social determinants of health are the most likely to experience unintended pregnancy, and the most likely to have that pregnancy result in an unplanned birth, and yet conversely have the fewest resources to manage the additional demands of an unplanned birth. Consumer cost for contraception is the Providing most commonly cited barrier to achieving desired pregnancy complete subsidy timing and spacing. Government has an opportunity to for highly effective improve outcomes and reduce costs by reducing the rate contraception to all female of unintended pregnancy when providing subsidy for the residents of BC would reduce most effective contraception. This policy results in the lowest overall health system cost. pregnancies by an average of 12.8% annually within four years Is it more expensive for a health system to pay for (including 21.0% fewer pregnancies the care of unintended pregnancies, or to subsidize among those under age 30), contraception? with cost equilibration after two years, and Canadian health systems have not been able to answer this savings of $27M question as neither pregnancy intention nor contraception annually starting method use prevalence has previously been measured. To answer this question for BC, we conducted a door-to-door in year four. IV British COLUmbia’S Contraception Access SUbsidY (BCAS) Cost Difference between Status Quo and the BCAS Policy for Pregnancy, Contraception, and Overall, by year Cost Difference Between Status Quo and BCAS Policies BCAS Policy Policy 1 Policy 2 45 35 25 Contraception Cost Difference (Dashed) 15 5 - 5 Total Net Difference (Solid) Cost Neutrality For BCAS vs Status Quo Cost (Millions of Dollars) - 1 5 Among All Women -2 5 -3 5 Pregnancy Cost Difference -4 5 (Dotted) 1 2 3 4 Year Status Quo: Results expected with no policy change indicated by the Red Line of Zero Cost Difference BCAS 1: Results expected with a policy of subsidy for contraception for all BC residents BCAS 2: Results expected with a policy of subsidy for contraception among BC residents under age 30 years Contraception Cost-EFFectiveness in British COLUmbia 2018 V Developing the Model Project Overview Our team developed a simulation model predicting the achieve their goals for timing and spacing pregnancies. occurrence and outcomes of pregnancies in BC and the We have incorporated new primary data from BC, collected associated costs, which is suited to inform decision-making through a high quality representative sample household relating to the provision of subsidy for contraception. The survey, as well as secondary evidence from existing tool is intended to support evidence-informed policy research by members of the team, and from the highest development to equitably support British Columbians to quality evidence available in published literature. Background Decision makers in health care are frequently expected to informed decision making on contraception access for BC make choices in an evidentiary and analytic vacuum. This is populations. The CART-CCM policy-research partnership an unacceptable state of affairs and one that the BC Ministry collaborated with BC Ministry of Health, Population and of Health is working to address across the health sector Public Health division staff to determine the evidence policy broadly. (2) Our project’s starting point was policy making makers require to support policy-making. This report details relating to access to contraception, with a particular focus on our findings with respect to the potential for cost-aversion the needs of vulnerable subgroups and the unique features strategies to support the equitable provision of affordable, of British Columbian contexts. The Contraception Access effective, accessible and culturally-appropriate contraception. Research Team (CART) Contraception Cost-effectiveness The BC Ministry of Health has identified the need to improve Modelling Study (CART-CCM, funded by MSFHR and CIHR) access to contraception as a key health priority. The Provincial was undertaken to address this gap and foster evidence- Health Officer’s report “The Health and Well-being of Women Contraception Cost-EFFectiveness in British COLUmbia 2018 1 in British Columbia” released in Dec. 2011(3) highlighted among this group indicating income and education among summary recommendations including: the highest levels in Canada, withdrawal was the third most commonly reported method of contraception among those • Improve access to contraception, especially long-acting at risk for pregnancy but not desiring to conceive, with 15% of reversible contraception; the same group reporting no contraceptive use at all. • Improve access to and coverage of sex education services, The Black findings are consistent with gaps identified by the principles of which should include the following: Access knowledge user partners and community stakeholders to contraception is unimpeded or even free. across BC(23, 47, 48, 90-92) indicating (even among our most Family planning is acknowledged to be one of the top affluent citizens) consumer cost of contraception influences ten public health advances of the millennium.(4) Health consumer preference for the least effective (and least costly) policy supporting accessible family planning has proven methods, in turn generating health system costs for provision value, leading to population-level gains in terms of health of abortion and management of unintended births. In high equity in high-income countries around the world.(5-22) income countries the rate of unintended pregnancy resulting Disadvantaged and vulnerable populations, particularly in birth is roughly equal to those resulting in abortion.(41, 42, 60, 62, youth, those of low socio-economic status or subjected 65, 93) In Canada, a third of women have at least one abortion.(89) to Adverse Childhood Experiences (ACES) and/or intimate Further, unintended pregnancies resulting in birth are partner violence, those living with substance use and associated with higher rates of smoking and substance use mental health disorders, residents in rural and remote during pregnancy, lower rates of breastfeeding,
Load more

Recommended publications
  • Heroin-Assisted Treatment and SNAP Activism in the Downtown Eastside of Vancouver Susan Boyd1, Dave Murray2, SNAP2 and Donald Macpherson3*
    Boyd et al. Harm Reduction Journal (2017) 14:27 DOI 10.1186/s12954-017-0152-3 RESEARCH Open Access Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver Susan Boyd1, Dave Murray2, SNAP2 and Donald MacPherson3* Abstract Background: This article highlights the experiences of a peer-run group, SALOME/NAOMI Association of Patients (SNAP), that meets weekly in the Downtown Eastside of Vancouver, British Columbia, Canada. SNAP is a unique independent peer- run drug user group that formed in 2011 following Canada’s first heroin-assisted treatment trial (HAT), North America Opiate Medication Initiative (NAOMI). SNAP’s members are now made up of former research participants who participated in two heroin-assisted trials in Vancouver. This article highlights SNAP members’ experiences as research subjects in Canada’s second clinical trial conducted in Vancouver, Study to Assess Longer-term Opioid Medication Effectiveness (SALOME), that began recruitment of research participants in 2011. Methods: This paper draws on one brainstorming session, three focus groups, and field notes, with the SALOME/NAOMI Association of Patients (SNAP) in late 2013 about their experiences as research subjects in Canada’s second clinical trial, SALOME in the DTES of Vancouver, and fieldwork from a 6-year period (March 2011 to February 2017) with SNAP members. SNAP’s research draws on research principles developed by drug user groups and critical methodological frameworks on community-based research for social justice. Results: The results illuminate how participating in the SALOME clinical trial impacted the lives of SNAP members. In addition, the findings reveal how SNAP member’s advocacy for HAT impacts the group in positive ways.
    [Show full text]
  • Collaborative Data Governance to Support First Nations-Led Overdose Surveillance and Data Analysis in British Columbia, Canada
    I N T E R N A T I O N A L J O U R N A L O F I N D I G E N O U S H E A L T H Promising Practice Collaborative Data Governance to Support First Nations-Led Overdose Surveillance and Data Analysis in British Columbia, Canada Soha Sabeti, Chloé Xavier, Amanda Slaunwhite, Louise Meilleur, Laura MacDougall, Snehal Vaghela, Davis McKenzie, Margot Kuo, Perry Kendall, Ciaran Aiken, Mark Gilbert, Shannon McDonald, Bonnie Henry A R T I C L E I N F O A B S T R A C T Keywords: First Nations Peoples in the province of British Columbia (BC), Canada, have Overdose been disproportionately affected by the overdose crisis. In 2016, a public health Opioid emergency was declared by BC’s Provincial Health Officer (PHO) in response to First Nations the significant rise in opioid-related overdose deaths reported in BC. New Data governance surveillance systems were required to identify trends in overdose events and Administrative health data related deaths in the province as a whole, and for First Nations Peoples. Data sharing and analysis processes that adhered to the principles of OCAP® https://doi.org/10.32799/ijih.v16i2.33212 (ownership, control, access, and possession), and to the Truth and Reconciliation Commission of Canada’s Calls to Action, needed to be developed. The First Nations Health Authority (FNHA), BC Centre for Disease Control, PHO, and the BC Ministry of Health have worked collaboratively to facilitate identification of First Nations persons in surveillance data for appropriate analysis by FNHA.
    [Show full text]
  • NEWS YOU CAN USE for Immediate Release Ministry of Health 2018HLTH0007-000123 Jan
    NEWS YOU CAN USE For Immediate Release Ministry of Health 2018HLTH0007-000123 Jan. 31, 2018 Third time’s the charm: Dr. Perry Kendall, provincial health officer, enters retirement VICTORIA – Dr. Perry Kendall is a legend among reporters, policymakers and the public-health world. One only need look at his office, with plaques, diplomas, an Order of B.C. and other awards covering every available space on the walls. All were well-earned during his lengthy tenure as B.C.’s provincial health officer (PHO). Still, it’s not awards and accolades that British Columbians will remember most about Dr. Kendall’s work. They will remember the kind and sharp leader, a person whose philosophy meant digging deep into the most-divisive and thorny issues facing families and people each day. “I was able to successfully step into roles independently, and maintain a progressive approach to the hot topics like the overdose crisis, harm reduction and the creation of Insite in Vancouver in 2003,” Dr. Kendall said. This ability did not come naturally. He laughs when recounting a reporter who called him during his first year as PHO, asking for an opinion on a policy. “Without checking on background, I told the reporter the policy was either really inane or really stupid. A few days later, a friend and colleague of mine called me up and said I must be taking this independent thing really seriously, because I was quoted as saying the health minister at the time was either really inane or really stupid! Fortunately, the minister had a sense of humour and never let my gaffe interfere with the professional relationship.” That incident taught Dr.
    [Show full text]
  • Dr. Kendall and Dr. Gustafson, Transcripts, February 17, 2021
    Long-Term Care COVID-19 Commission Meeting Dr. Réka Gustafson and Dr. Perry Kendall on Wednesday, February 17, 2021 77 King Street West, Suite 2020 Toronto, Ontario M5K 1A1 neesonsreporting.com | 416.413.7755 Long-Term Care COVID-19 Commission Meeting Dr. Réka Gustafson and Dr. Perry Kendall on 2/17/2021 1 1 2 3 4 5 6 7 MEETING OF THE LONG-TERM CARE COVID-19 COMMISSION 8 9 10 11 12 13 -------- 14 --- Held via Zoom Videoconferencing, with all 15 participants attending remotely, on the 17th day of 16 February, 2021, 11:00 a.m. to 1:00 p.m. 17 -------- 18 19 20 21 22 23 24 25 neesonsreporting.com 416.413.7755 Long-Term Care COVID-19 Commission Meeting Dr. Réka Gustafson and Dr. Perry Kendall on 2/17/2021 2 1 BEFORE: 2 3 The Honourable Frank N. Marrocco, Commission Chair 4 Angela Coke, Commissioner 5 Dr. Jack Kitts, Commissioner 6 7 8 PRESENTERS: 9 10 BC CENTRE FOR DISEASE CONTROL, PROVINCIAL HEALTH 11 SERVICES AUTHORITY: 12 Dr. Réka Gustafson, Vice President, Public Health 13 and Wellness, Provincial Health Services Authority, 14 and Deputy Provincial Health Officer 15 Dr. Perry Kendall, Public Health Consultant, Past 16 BC Provincial Health Officer (1999-2018) 17 18 PARTICIPANTS: 19 20 John Callaghan, Co-Lead Commission Counsel, Gowling 21 WLG 22 Lynn Mahoney, Counsel, Gowling WLG 23 Michael Finley, Counsel, Gowling WLG 24 Jennifer King, Counsel, Gowling WLG 25 Alison Drummond, Assistant Deputy Minister, neesonsreporting.com 416.413.7755 Long-Term Care COVID-19 Commission Meeting Dr. Réka Gustafson and Dr.
    [Show full text]
  • Stopping the Harm: Decriminalization of People Who Use Drugs in BC
    STOPPING THE HARM DECRIMINALIZATION OF PEOPLE WHO USE DRUGS IN BC PROVINCIAL HEALTH OFFICER’S SPECIAL REPORT TABLE OF CONTENTS Acknowledgements .........................................................................................................................2 Executive Summary .........................................................................................................................3 The Overdose Crisis in BC ..............................................................................................................3 Decriminalization of People Who Use Drugs ................................................................................4 Chapter 1: The Illegal Drug Overdose Crisis in BC ..................................................................6 Illegal Drug Overdoses in BC..........................................................................................................6 BC’s Illegal Street Drug Supply is Highly Toxic .............................................................................7 BC’s Response to the Overdose Crisis ..........................................................................................8 Pharmaceutical Alternatives to Street Drugs as Part of a Harm Reduction Approach ........8 Key Messages .................................................................................................................................9 Chapter 2: History of Canada’s Drug Laws, National Strategies, and International Drug Conventions .........................................................................................................................
    [Show full text]